Agfa-Gevaert : Press release

Agfa-Gevaert : Press release

ID: 510485

(Thomson Reuters ONE) -


Mortsel, Belgium - December 1, 2016 - 10.30 p.m. CET


Reference is made to the press releases issued on October 28 and November
8, 2016.

As communicated previously, Agfa-Gevaert NV ("Agfa") was approached by
CompuGroup Medical SE ("CompuGroup"), who had indicated an interest in a
potential acquisition of all of the issued shares of Agfa by way of a voluntary
conditional public takeover offer.

Taking into account the interests of its shareholders and other stakeholders,
the Board of Directors of Agfa decided on November 8 to engage into a non-
exclusive discussion with CompuGroup and wants to provide an update to the
market and investors.

Agfa and CompuGroup have reached an understanding today to not further pursue
the discussions about the contemplated public takeover bid.

(End of message)


About Agfa
The Agfa-Gevaert Group develops, manufactures and distributes an extensive range
of analogue and digital imaging systems and IT solutions, mainly for the
printing industry and the healthcare sector, as well as for specific industrial
applications.
Agfa's headquarters and parent company are located in Mortsel, Belgium.
The Agfa-Gevaert Group achieved a turnover of 2,646 million euro in 2015.


Contact:
Viviane Dictus
Director Corporate Communications
tel. ++32 0 3 444 7124
e-mail: viviane.dictus(at)agfa.com

Johan Jacobs
Corporate Press Relations Manager
tel. ++32 0 3 444 8015
e-mail: johan.jacobs(at)agfa.com



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Agfa-Gevaert via GlobeNewswire








Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Eastman Board Increases Dividend for Seventh Consecutive Year Basilea expands oncology drug candidate BAL101553 clinical phase 1/2a oral study to include glioblastoma patients
Bereitgestellt von Benutzer: hugin
Datum: 01.12.2016 - 22:30 Uhr
Sprache: Deutsch
News-ID 510485
Anzahl Zeichen: 2086

contact information:
Town:

Mortsel



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 287 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Agfa-Gevaert : Press release"
steht unter der journalistisch-redaktionellen Verantwortung von

Agfa-Gevaert (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Agfa-Gevaert



 

Werbung



Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z